Home » Stocks » CERC

Cerecor Inc. (CERC)

Stock Price: $2.58 USD 0.08 (3.20%)
Updated December 1, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 193.27M
Revenue (ttm) -3.52M
Net Income (ttm) -46.24M
Shares Out 74.91M
EPS (ttm) -0.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 1
Last Price $2.58
Previous Close $2.50
Change ($) 0.08
Change (%) 3.20%
Day's Open 2.56
Day's Range 2.50 - 2.63
Day's Volume 359,871
52-Week Range 1.70 - 5.71

More Stats

Market Cap 193.27M
Enterprise Value 159.74M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 74.91M
Float n/a
EPS (basic) -0.67
EPS (diluted) -0.82
FCF / Share -0.37
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.37M
Short Ratio 6.36
Short % of Float n/a
Beta 1.70
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 4.98
Revenue -3.52M
Operating Income -56.17M
Net Income -46.24M
Free Cash Flow -27.91M
Net Cash 33.52M
Net Cash / Share 0.45
Gross Margin -84.37%
Operating Margin 1,595.25%
Profit Margin 1,313.00%
FCF Margin 792.51%
ROA -40.15%
ROE -189.74%
ROIC 3,756.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$9.00*
Low
9.00
Current: $2.58
High
9.00
Target: 9.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue6.757.0327.811.15---
Revenue Growth-3.96%-74.73%2312.27%----
Gross Profit7.323.7727.181.15---
Operating Income-17.39-35.4913.89-16.08-11.01-17.12-12.93
Net Income-16.07-40.057.77-16.47-10.49-3.52-13.13
Shares Outstanding44.1134.7718.418.832.230.640.63
Earnings Per Share-0.28-1.200.42-1.87-4.71-5.48-20.72
Operating Cash Flow-19.13-3.1312.58-14.57-10.16-15.52-11.49
Capital Expenditures-0.26-0.56-0.02-0.03-0.02-0.02-0.03
Free Cash Flow-19.40-3.6912.56-14.61-10.18-15.54-11.51
Cash & Equivalents11.2610.672.475.1421.2211.803.42
Total Debt---2.355.567.21-
Net Cash / Debt11.2610.672.472.7915.664.593.42
Assets36.1170.2542.815.7721.6612.325.08
Liabilities15.1149.3414.955.568.5710.303.07
Book Value21.0020.9127.860.2113.08-26.33-17.85
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Cerecor Inc.
Country United States
Employees 18
CEO Michael F. Cola

Stock Information

Ticker Symbol CERC
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: CERC
IPO Date October 15, 2015

Description

Cerecor, a biopharmaceutical company, focuses on development and commercialization of treatments for rare pediatric and orphan diseases. It develop therapies for the treatment of inherited metabolic disorders, such as CERC-801 and CERC-802, which completed the phase I clinical trial; and CERC-803. The company is also involved in the developing of CERC-007, an anti-IL-18 monoclonal antibody for the treatment of autoimmune inflammatory diseases, such as adult onset stills disease and multiple myeloma; CERC-006, a dual mTOR inhibitor to treat complex lymphatic malformations; and CERC-002, an anti-LIGHT monoclonal antibody for the treatment of Pediatric-onset Crohn's diseases. In addition, it develops CERC-913, a protide nucleotide for the treatment of mitochondrial disorder; CERC-005, a monoclonal antibody to treat rare auto-inflammatory diseases; CERC-301 for the treatment of symptomatic Orthostatic Hypotension; and CERC-406 for the treatment of Parkinson's disease. Further, the company offers Millipred, an oral prednisolone for the treatment of inflammatory conditions, such as arthritis, blood disorders, immune system disorders, skin and eye conditions, respiratory disorders, cancer, and severe allergies. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.